$GNTOF
GENTOR RESOURCES INC. Stock $gntof

$gntof Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000106299324009037 Filed on April 30, 2024

Income Statement

Concept	2023 Q4	2023
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$84.94K	$218.7K
YoY Change	8.33%	-21.04%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$84.94K	$218.7K
YoY Change	8.34%	-21.04%
Operating Profit		-$219.6K
YoY Change		-20.97%
Interest Expense	$5.300K	-$2.960K
YoY Change	-250.57%	-151.84%
% of Operating Profit
Other Income/Expense, Net	-$11.45K	$288.3K
YoY Change	-579.08%	2056.1%
Pretax Income	-$91.09K	$66.59K
YoY Change	14.52%	-125.82%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings	-$91.09K	$66.59K
YoY Change	14.52%	-125.82%
Net Earnings / Revenue
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	38.91M shares	38.91M shares
Diluted Shares Outstanding		38.91M shares

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$26.70K	$26.70K
YoY Change	172.45%	172.45%
Cash & Equivalents	$26.70K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses	$3.709K
Receivables
Other Receivables	$18.99K
Total Short-Term Assets	$45.69K	$45.69K
YoY Change	82.16%	82.1%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$45.69K	$45.69K
Total Long-Term Assets	$0.00	$0.00
Total Assets	$45.69K	$45.69K
YoY Change	82.16%	82.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$107.2K	$107.2K
YoY Change	-7.56%	-7.56%
Accrued Expenses	$97.42K	$97.42K
YoY Change	55.84%	55.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.020M	$1.020M
YoY Change	-4.39%	-4.39%
LONG-TERM LIABILITIES
Long-Term Debt	$26.87K	$26.87K
YoY Change	3.46%	3.43%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$26.87K	$26.87K
YoY Change	3.46%	3.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.020M	$1.020M
Total Long-Term Liabilities	$26.87K	$26.87K
Total Liabilities	$1.047M	$1.047M
YoY Change	-4.21%	-4.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$44.36M
YoY Change	-0.15%
Common Stock	$43.36M
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.001M	-$1.001M
YoY Change
Total Liabilities & Shareholders Equity	$45.69K	$45.69K
YoY Change	82.16%	82.1%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$91.09K	$66.59K
YoY Change	14.52%	-125.82%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$25.66K	-$101.3K
YoY Change	348.6%	-1872.12%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities	25.66K	-$101.3K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash	25.66K	-$101.3K
YoY Change	348.6%	-1872.12%
FREE CASH FLOW
Cash From Operating Activities	$25.66K	-$101.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001346917
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	333-130386
CY2023	dei	Entity Registrant Name EntityRegistrantName	GENTOR RESOURCES INC.
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	4120 Yonge Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 304
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Toronto
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A6
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	M2P 2B8
CY2023	dei	Entity Address Country EntityAddressCountry	CA
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	38906742	shares
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Location AuditorLocation	Markham, Canada
CY2023Q4	us-gaap	Cash Cash	26703	usd
CY2022Q4	us-gaap	Cash Cash	9803	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	18991	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	15282	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	45694	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	25085	usd
CY2023Q4	us-gaap	Assets Assets	45694	usd
CY2022Q4	us-gaap	Assets Assets	25085	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	107212	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	115976	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	97419	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	62514	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1020094	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1066974	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	26874	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25976	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1046968	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1092950	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0008
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0008
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38906742	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38906742	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38906742	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38906742	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	31125	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	43325272	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	43325272	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44357671	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44424262	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1001274	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1067865	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	45694	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25085	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	50952	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	24374	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	60474	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	142971	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	154826	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	155346	usd
CY2023	gntof	Rent Expense RentExpense	0	usd
CY2022	gntof	Rent Expense RentExpense	55602	usd
CY2021	gntof	Rent Expense RentExpense	59526	usd
CY2023	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	0	usd
CY2022	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	0	usd
CY2021	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	1383	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11304	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18596	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16795	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13502	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23602	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18545	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	896	usd
CY2021	us-gaap	Accretion Expense AccretionExpense	897	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-219627	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-277896	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-312966	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	32	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2058	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6605	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	114	usd
CY2023	gntof	Writeback Of Accounts Payable And Accrued Liabilities WritebackOfAccountsPayableAndAccruedLiabilities	-288274	usd
CY2022	gntof	Writeback Of Accounts Payable And Accrued Liabilities WritebackOfAccountsPayableAndAccruedLiabilities	-13370	usd
CY2021	gntof	Writeback Of Accounts Payable And Accrued Liabilities WritebackOfAccountsPayableAndAccruedLiabilities	-334014	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	66591	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-257913	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	66591	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-257913	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21194	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38906742	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38906742	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38906742	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38906742	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38906742	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38906742	shares
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	66591	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-257913	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21194	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	898	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	896	usd
CY2021	us-gaap	Accretion Expense AccretionExpense	897	usd
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	0	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	0	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	88665	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	300107	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	292896	usd
CY2023	gntof	Increase Decrease In Advances Receivable IncreaseDecreaseInAdvancesReceivable	3709	usd
CY2022	gntof	Increase Decrease In Advances Receivable IncreaseDecreaseInAdvancesReceivable	-734	usd
CY2021	gntof	Increase Decrease In Advances Receivable IncreaseDecreaseInAdvancesReceivable	679	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8764	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-28336	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-241564	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	34905	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9770	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-69771	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5718	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	16900	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5718	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3292	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9803	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4085	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26703	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9803	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4085	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-831146	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	21194	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-809952	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-257913	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1067865	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	66591	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1001274	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	66591	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-257913	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21194	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44357671	usd
CY2023	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-974400	usd
CY2022	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-1041889	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y5M26D
CY2023Q4	gntof	Unsecured Loan Receivable UnsecuredLoanReceivable	15282	usd
CY2022Q4	gntof	Unsecured Loan Receivable UnsecuredLoanReceivable	15282	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3709	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	0	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0008
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38906742	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38906742	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38906742	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38906742	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1040000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.065
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y5M26D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1040000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.065
CY2023Q4	gntof	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Fair Value Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageFairValuePrice	0.065
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y5M26D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.014	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0153	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.1933	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.1956	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023	gntof	Unrecognized Stock Based Compensation Expense UnrecognizedStockBasedCompensationExpense	0	usd
CY2022	gntof	Unrecognized Stock Based Compensation Expense UnrecognizedStockBasedCompensationExpense	0	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38906742	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38906742	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38906742	shares
CY2023	gntof	Income Tax Reconciliation Gain Loss For Year IncomeTaxReconciliationGainLossForYear	53976	usd
CY2022	gntof	Income Tax Reconciliation Gain Loss For Year IncomeTaxReconciliationGainLossForYear	-257913	usd
CY2021	gntof	Income Tax Reconciliation Gain Loss For Year IncomeTaxReconciliationGainLossForYear	-48023	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	11000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-54000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-10000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	0	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	0	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-64976	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	55575	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-0	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	0	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14476000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14482000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	25540000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	25540000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	108000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	108000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	65000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	65000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	40189000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	40195000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	14530000	usd
CY2023	gntof	Foreign Currency Strength Percentage ForeignCurrencyStrengthPercentage	0.10	pure
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Auditor Firm AuditorFirmId	6644
CY2023	dei	Auditor Name AuditorName	Kreston GTA LLP
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	815463	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	888484	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	31125	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	898	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	21194	usd
CY2023	gntof	Writeback Of Accounts Payable WritebackOfAccountsPayable	288274	usd
CY2022	gntof	Writeback Of Accounts Payable WritebackOfAccountsPayable	0	usd
CY2021	gntof	Writeback Of Accounts Payable WritebackOfAccountsPayable	0	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized After Tax ForeignCurrencyTransactionGainLossUnrealizedAfterTax	-8358	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized After Tax ForeignCurrencyTransactionGainLossUnrealizedAfterTax	0	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized After Tax ForeignCurrencyTransactionGainLossUnrealizedAfterTax	0	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-319	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-101330	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3292	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	118230	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	793	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<div> <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1.<span style="width: 28pt; text-indent: 0pt; display: inline-block;"> </span>NATURE OF OPERATIONS AND GOING CONCERN</span></span></p> <p style="margin-left: 36pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">NATURE OF OPERATIONS</span></span></p> <p style="margin-left: 36pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Gentor Resources Inc. (the "Company" or "Gentor"), a Cayman Islands corporation, is an exploration stage corporation formed for the purpose of prospecting and developing mineral properties. </span></span></p> <p style="margin-left: 36pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The business of exploring for minerals involves a high degree of risk. Few properties that are explored are ultimately developed into producing mines. Major expenses may be required to establish ore reserves, to develop metallurgical processes, to acquire construction and operating permits and to construct mining and processing facilities. Having relinquished its only project (the Karaburun project in Turkey) effective at the end of 2017, the Company currently does not have any commercial operations and has no material assets. The Company is currently evaluating new business opportunities.</span></span></p> <p style="margin-left: 36pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">GOING CONCERN</span></span></p> <p style="margin-left: 36pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The accompanying audited consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the year ended December 31, 2023, the Company had a net income and comprehensive income of $66,591 (2022 - net loss and comprehensive loss of $257,913 and 2021 - net income and comprehensive income of $21,194, respectively). The Company also had a deficit accumulated during the exploration stage of $44,357,671 as at December 31, 2023 (December 31, 2022 - $44,424,262), and a working capital deficiency of $974,400 as at December 31, 2023 (December 31, 2022 - working capital deficiency of $1,041,889).</span></span></p> <p style="margin-left: 36pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company intends to fund operations through equity financing arrangements. Such financings may be insufficient to fund its ongoing working capital and other cash requirements. The Company's continued existence is dependent upon it emerging from the exploration stage, obtaining additional financing to continue operations, exploring and developing mineral properties and the discovery, development and sale of ore reserves.</span></span></p> <p style="margin-left: 36pt; text-align: justify; margin-bottom: 0pt; margin-top: 0pt;"><span style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-family: Times New Roman, Times, serif; margin-top: 0pt; margin-bottom: 0pt;">These circumstances represent material uncertainties which cast substantial doubt on the Company's ability to continue on a going concern basis. These audited consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern. Such adjustments may be material.</span></span></p> </div>
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44424262	usd
CY2023	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<div> <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">d) ASSET IMPAIRMENT</span></span></p> <p style="margin-left: 36pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company monitors events and changes in circumstances, which may require an assessment of the recoverability of its long-lived assets. If required, the Company would assess recoverability using estimated undiscounted future operating cash flows of the related asset or asset grouping. Assets are grouped at the lowest levels for which there are identifiable cash flows that are largely independent of the cash flows generated by other asset groups. If the carrying amount of an asset is not recoverable, an impairment loss is recognized in operations, measured by comparing the carrying amount of the asset to its fair value. No impairment losses or reversals of previously recorded impairments were recorded during the years ended December 31, 2023, 2022 and 2021.</span></span></p> </div>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">i) USE OF ESTIMATES</span></span></p> <p style="margin-left: 36pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of income and expenses during the reporting period. Actual results could differ from management's best estimates as additional information becomes available in the future. The Company bases its estimates and assumptions on historical experience, current facts, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Significant estimates and assumptions include those related to estimation of deferred income taxes, tax loss recoverability and fair value estimates for stock options.</span></span></p> </div>
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.065
CY2021Q4	gntof	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Fair Value Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageFairValuePrice	0.065
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1040000	shares
CY2022Q4	gntof	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Fair Value Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageFairValuePrice	0.065
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-1575	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	10000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	14530000	usd
CY2023	gntof	Foreign Currency Weakness Percentage ForeignCurrencyWeaknessPercentage	0.10	pure

Files In Submission

Name	View Source	Status
0001062993-24-009037-index-headers.html	Edgar Link	pending
0001062993-24-009037-index.html	Edgar Link	pending
0001062993-24-009037.txt	Edgar Link	pending
0001062993-24-009037-xbrl.zip	Edgar Link	pending
exhibit12-1.htm	Edgar Link	pending
exhibit12-2.htm	Edgar Link	pending
exhibit13-1.htm	Edgar Link	pending
exhibit13-2.htm	Edgar Link	pending
exhibit15-1.htm	Edgar Link	pending
exhibit15-1x001.jpg	Edgar Link	pending
exhibit2-1.htm	Edgar Link	pending
exhibit4-1.htm	Edgar Link	pending
exhibit8-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form20f.htm	Edgar Link	pending
form20fxz001.jpg	Edgar Link	pending
form20fxz002.jpg	Edgar Link	pending
form20fxz003.jpg	Edgar Link	pending
form20fxz004.jpg	Edgar Link	pending
gntof-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gntof-20231231_cal.xml	Edgar Link	unprocessable
gntof-20231231_lab.xml	Edgar Link	unprocessable
gntof-20231231_pre.xml	Edgar Link	unprocessable
form20f_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
gntof-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GNTOF
GENTOR RESOURCES INC. Stock $gntof

2023 Q4 Form 20-F Financial Statement

#000106299324009037 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNTOF GENTOR RESOURCES INC. Stock $gntof

2023 Q4 Form 20-F Financial Statement

#000106299324009037 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNTOF
GENTOR RESOURCES INC. Stock $gntof